“Keith Crandell”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  5/13/24  as  ↓Group Member

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Keith Crandell” has been a Group Member with  11  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
5/13/24		IL	ARCH Venture Fund VIII, L.P.	19	SC 13G/A	MA	Q32 Bio Inc.
2/22/24		IL	ARCH Venture Fund XII, L.P.	3	SC 13D	MA	Prime Medicine, Inc.
2/14/24		IL	ARCH Venture Fund IX, L.P.	23	SC 13G/A	CA	Lyell Immunopharma, Inc.
2/9/24		IL	ARCH Venture Fund VII, L.P.	41	SC 13G/A	MA	908 Devices Inc.
11/17/23		IL	ARCH Venture Fund X, L.P.	6	SC 13G/A	MA	EQRx, Inc.
8/4/23		IL	ARCH Venture Fund XI, L.P.	2	SC 13D/A	NY	DA32 Life Science Tech Acquisition Corp.
7/25/23		IL	Arch Venture Fund VI LP	33	SC 13D/A	MA	Vbi Vaccines Inc.
2/14/20		IL	Arch Venture Fund V LP	14	SC 13G/A	WA	Impinj Inc.
2/11/08		IL	Arch Venture Fund IV LP	5	SC 13G/A	CA	Xenoport Inc.
10/6/05		IL	Arch Venture Fund III LP	19	SC 13G/A	IL	Apropos Technology Inc.
2/10/99		IL	Arch Venture Fund II LP	4	SC 13G/A	IL	Nanophase Technologies Corp.

“Keith Crandell” has/had a Group Member interest in  57  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
5/13/24		MA	Q32 Bio Inc.	3	SC 13G/A	IL	ARCH Venture Fund VIII, L.P.
2/22/24		MA	Prime Medicine, Inc.	2	SC 13D	IL	ARCH Venture Fund XII, L.P.
2/14/24		CA	Lyell Immunopharma, Inc.	2	SC 13G/A	IL	ARCH Venture Fund IX, L.P.
2/14/24		MA	Beam Therapeutics Inc.	3	SC 13G/A	IL	ARCH Venture Fund IX, L.P.
2/14/24		MA	Scholar Rock Holding Corp.	3	SC 13G/A	IL	ARCH Venture Fund VIII, L.P.
2/9/24		WA	Sana Biotechnology, Inc.	3	SC 13G/A	IL	ARCH Venture Fund IX, L.P.
2/9/24		CA	Gossamer Bio, Inc.	2	SC 13G/A	IL	ARCH Venture Fund IX, L.P.
2/9/24		MA	908 Devices Inc.	4	SC 13G/A	IL	ARCH Venture Fund VII, L.P.
12/15/23		MA	Neumora Therapeutics, Inc.	2	SC 13D/A	IL	ARCH Venture Fund XII, L.P.
11/17/23		MA	EQRx, Inc.	2	SC 13G/A	IL	ARCH Venture Fund X, L.P.
8/4/23		NY	DA32 Life Science Tech Acquisition Corp.	2	SC 13D/A	IL	ARCH Venture Fund XI, L.P.
7/25/23		MA	Vbi Vaccines Inc.	4	SC 13D/A	IL	Arch Venture Fund VI LP
2/13/23		MA	Verve Therapeutics, Inc.	2	SC 13G/A	IL	ARCH Venture Fund X, L.P.
9/20/22		MA	Karuna Therapeutics, Inc.	5	SC 13D/A	IL	ARCH Venture Fund IX, L.P.
9/20/22		MA	Codiak BioSciences, Inc.	2	SC 13D	IL	ARCH Venture Fund VIII, L.P.
9/13/22		CA	Vir Biotechnology, Inc.	7	SC 13D/A	IL	ARCH Venture Fund IX, L.P.
2/11/22		CA	Unity Biotechnology, Inc.	4	SC 13G/A	IL	ARCH Venture Fund VII, L.P.
2/10/22		CA	Erasca, Inc.	1	SC 13G	IL	ARCH Venture Fund X, L.P.
2/8/22		CA	Denali Therapeutics Inc.	4	SC 13G/A	IL	ARCH Venture Fund VIII, L.P.
2/4/22		CA	Singular Genomics Systems, Inc.	1	SC 13G	IL	ARCH Venture Fund IX, L.P.
			More...  Please Sign In to list all 57 of them.

“Keith Crandell” has been a Group Member with  51  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
5/13/24		IL	Arch Venture Fund VIII Overage, L.P.	21	SC 13G/A	IL	ARCH Venture Fund VIII, L.P.	MA	Q32 Bio Inc.
		IL	ARCH Venture Partners VIII, L.P.	19
		IL	ARCH Venture Partners VIII, LLC.	32
		IL	Clinton Bybee	155
		IL	Robert Nelsen	167
2/22/24		IL	Arch Venture Fund X Overage, L.P.	15	SC 13D	IL	ARCH Venture Fund XII, L.P.	MA	Prime Medicine, Inc.
		IL	Arch Venture Fund X, L.P.	6
		IL	ARCH Venture Partners X Overage, L.P.	15
		IL	ARCH Venture Partners X, L.P.	12
		IL	ARCH Venture Partners X, LLC.	15
		IL	ARCH Venture Partners XII, L.P.	3
		IL	ARCH Venture Partners XII, LLC	3
		IL	Kristina Burow	17
		IL	Steven Gillis	16
2/14/24		IL	Arch Venture Fund IX Overage, L.P.	22	SC 13G/A	IL	ARCH Venture Fund IX, L.P.	CA	Lyell Immunopharma, Inc.
		IL	ARCH Venture Partners IX Overage, L.P.	22
		IL	ARCH Venture Partners IX, L.P.	23
		IL	ARCH Venture Partners IX, LLC	23
2/9/24		IL	ARCH Venture Partners VII, L.P.	43	SC 13G/A	IL	ARCH Venture Fund VII, L.P.	MA	908 Devices Inc.
		IL	ARCH Venture Partners VII, LLC	43
			More...  Please Sign In to list all 51 of them.

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Keith Crandell” has been a Signatory for/with  46  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
11/21/23		CA	Twist Bioscience Corp.	9	S-8	—
9/14/23		IL	ARCH Venture Fund XII, L.P.	1	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Partners X, LLC	6	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Partners XII, L.P.	1	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Partners XII, LLC	1	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	Bybee Clinton	20	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	Crandell Keith	28	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	Gillis Steven	6	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	Nelsen Robert	15	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Fund VII, L.P.	12	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Fund VIII Overage, L.P.	4	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Fund X Overage, L.P.	5	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Fund X, L.P.	5	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Partners VII, L.P.	6	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Partners VII, LLC	6	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Partners VIII, LLC	5	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Partners X Overage, L.P.	5	3	MA	Neumora Therapeutics, Inc.
9/14/23		IL	ARCH Venture Partners X, L.P.	4	3	MA	Neumora Therapeutics, Inc.
8/10/23		IL	ARCH Venture Fund XI, L.P.	1	4	NY	DA32 Life Science Tech Acquisition Corp.
8/10/23		IL	ARCH Venture Partners XI, L.P.	1	4	NY	DA32 Life Science Tech Acquisition Corp.
			More...  Please Sign In to list all 46 of them.

“Keith Crandell” has/had a Signatory interest in  30  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
9/14/23		MA	Neumora Therapeutics, Inc.	2	3	IL	Crandell Keith
8/10/23		NY	DA32 Life Science Tech Acquisition Corp.	1	4	IL	Nelsen Robert
7/25/23		MA	Vbi Vaccines Inc.	2	SC 13D/A	IL	Arch Venture Fund VI LP
2/9/23		CA	Twist Bioscience Corp.	3	4	IL	Crandell Keith
10/19/22		MA	Prime Medicine, Inc.	1	3	IL	Crandell Keith
2/11/22		CA	Unity Biotechnology, Inc.	2	SC 13G/A	IL	ARCH Venture Fund VII, L.P.
2/8/22		CA	Denali Therapeutics Inc.	2	SC 13G/A	IL	ARCH Venture Fund VIII, L.P.
2/8/22		MA	908 Devices Inc.	3	SC 13G/A	IL	ARCH Venture Fund VII, L.P.
6/16/21		MA	Verve Therapeutics, Inc.	1	3	IL	Crandell Keith
2/4/21		MA	Codiak BioSciences, Inc.	2	SC 13G	IL	ARCH Venture Fund VIII, L.P.
2/3/21		WA	Sana Biotechnology, Inc.	2	3	IL	ARCH Venture Fund X, L.P.
2/2/21		CA	Metacrine, Inc.	3	SC 13G	IL	ARCH Venture Fund VIII, L.P.
2/2/21		MA	Syros Pharmaceuticals, Inc.	1	SC 13G/A	IL	ARCH Venture Fund VII, L.P.
2/2/21		MA	Quanterix Corp.	3	SC 13G/A	IL	Arch Venture Fund VI LP
2/5/20		MA	Beam Therapeutics Inc.	1	3	IL	ARCH Venture Partners IX, LLC
10/10/19		CA	Vir Biotechnology, Inc.	1	3	IL	ARCH Venture Partners IX, L.P.
6/27/19		MA	Karuna Therapeutics, Inc.	1	3	IL	ARCH Venture Partners IX, LLC
2/26/19		CA	Sienna Biopharmaceuticals, Inc.	3	4	IL	ARCH Venture Partners X, LLC
2/7/19		CA	Gossamer Bio, Inc.	1	3	IL	ARCH Venture Partners IX, LLC
7/20/16		WA	Impinj Inc.	1	3	IL	Arch Venture Partners V LLC
			More...  Please Sign In to list all 30 of them.